These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 39106497

  • 21. Complement Activation and Thrombotic Microangiopathy Associated With Monoclonal Gammopathy: A National French Case Series.
    Martins M, Bridoux F, Goujon JM, Meuleman MS, Ribes D, Rondeau E, Guerry MJ, Delmas Y, Levy B, Ducloux D, Kandel-Aznar C, Le Fur A, Garrouste C, Provot F, Gibier JB, Thervet E, Bruneval P, Rabant M, Karras A, Dragon Durey MA, Fremeaux-Bacchi V, Chauvet S.
    Am J Kidney Dis; 2022 Sep; 80(3):341-352. PubMed ID: 35217094
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Copy number variation analysis using next-generation sequencing identifies the CFHR3/CFHR1 deletion in atypical hemolytic uremic syndrome: a case report.
    Park J, Yhim HY, Kang KP, Bae TW, Cho YG.
    Hematology; 2022 Dec; 27(1):603-608. PubMed ID: 35617302
    [Abstract] [Full Text] [Related]

  • 24. Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review.
    de Holanda MI, Pôrto LC, Wagner T, Christiani LF, Palma LMP.
    Clin Rheumatol; 2017 Dec; 36(12):2859-2867. PubMed ID: 28905254
    [Abstract] [Full Text] [Related]

  • 25. Thrombotic Microangiopathy Syndromes-Common Ground and Distinct Frontiers.
    Hanna RM, Henriksen K, Kalantar-Zadeh K, Ferrey A, Burwick R, Jhaveri KD.
    Adv Chronic Kidney Dis; 2022 Mar; 29(2):149-160.e1. PubMed ID: 35817522
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies.
    Bu F, Borsa NG, Jones MB, Takanami E, Nishimura C, Hauer JJ, Azaiez H, Black-Ziegelbein EA, Meyer NC, Kolbe DL, Li Y, Frees K, Schnieders MJ, Thomas C, Nester C, Smith RJ.
    J Am Soc Nephrol; 2016 Apr; 27(4):1245-53. PubMed ID: 26283675
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Combined study of ADAMTS13 and complement genes in the diagnosis of thrombotic microangiopathies using next-generation sequencing.
    Fidalgo T, Martinho P, Pinto CS, Oliveira AC, Salvado R, Borràs N, Coucelo M, Manco L, Maia T, Mendes MJ, Del Orbe Barreto R, Corrales I, Vidal F, Ribeiro ML.
    Res Pract Thromb Haemost; 2017 Jul; 1(1):69-80. PubMed ID: 30046676
    [Abstract] [Full Text] [Related]

  • 30. Complement activation in diseases presenting with thrombotic microangiopathy.
    Meri S.
    Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
    [Abstract] [Full Text] [Related]

  • 31. Routine use of clinical exome-based next-generation sequencing for evaluation of patients with thrombotic microangiopathies.
    Gaut JP, Jain S, Pfeifer JD, Vigh-Conrad KA, Corliss M, Sharma MK, Heusel JW, Cottrell CE.
    Mod Pathol; 2017 Dec; 30(12):1739-1747. PubMed ID: 28752844
    [Abstract] [Full Text] [Related]

  • 32. Epidemiology, Outcomes, and Complement Gene Variants in Secondary Thrombotic Microangiopathies.
    Werion A, Storms P, Zizi Y, Beguin C, Bernards J, Cambier JF, Dahan K, Dierickx D, Godefroid N, Hilbert P, Lambert C, Levtchenko E, Meyskens T, Poiré X, van den Heuvel L, Claes KJ, Morelle J, UCLouvain TMA/HUS Network and KU Leuven TMA/HUS Network.
    Clin J Am Soc Nephrol; 2023 Jul 01; 18(7):881-891. PubMed ID: 37094330
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Post-Transplant Thrombotic Microangiopathy due to a Pathogenic Mutation in Complement Factor I in a Patient With Membranous Nephropathy: Case Report and Review of Literature.
    Saleem M, Shaikh S, Hu Z, Pozzi N, Java A.
    Front Immunol; 2022 Jul 01; 13():909503. PubMed ID: 35720299
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics.
    Gavriilaki E, Anagnostopoulos A, Mastellos DC.
    Front Immunol; 2019 Jul 01; 10():337. PubMed ID: 30891033
    [Abstract] [Full Text] [Related]

  • 38. Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy.
    Moscvin M, Liacos CI, Chen T, Theodorakakou F, Fotiou D, Hossain S, Rowell S, Leblebjian H, Regan E, Czarnecki P, Bagnoli F, Bolli N, Richardson P, Rennke HG, Dimopoulos MA, Kastritis E, Bianchi G.
    Blood Cancer J; 2023 Feb 27; 13(1):31. PubMed ID: 36849497
    [Abstract] [Full Text] [Related]

  • 39. Thrombotic microangiopathy: focus on atypical hemolytic uremic syndrome.
    Sperati CJ, Moliterno AR.
    Hematol Oncol Clin North Am; 2015 Jun 27; 29(3):541-59. PubMed ID: 26043391
    [Abstract] [Full Text] [Related]

  • 40. Thrombotic microangiopathy without renal involvement: two novel mutations in complement-regulator genes.
    Peyvandi F, Rossio R, Ferrari B, Lotta LA, Pontiggia S, Ghiringhelli Borsa N, Pizzuti M, Donadelli R, Piras R, Cugno M, Noris M.
    J Thromb Haemost; 2016 Feb 27; 14(2):340-5. PubMed ID: 26613809
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.